Koninklijke Philips Nv's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Koninklijke Philips Nv in the fourth quarter 2025?
Koninklijke Philips Nv achieved a return on average equity (ROE) of 8.16 % in its fourth quarter 2025, this is above PHG's average return on equity of 4.49%.
Koninklijke Philips Nvs equity during the 12 months ending in the fourth quarter 2025 are valued at $12 billion

ROE has advanced compared to -6.2% in the third quarter 2025, due to net income growth.

Within the Medical Laboratories industry 8 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 0 to 2800.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Equity Change	-8.74 %	-8.74 %	-8.74 %	-8.74 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	1,005	-782	-782	-782	-782
Return On Equity (TTM)	8.16 %	-6.2 %	-6.06 %	-5.93 %	-5.8 %
PHG's Total Ranking	# 2800	# 0	#	#	#
Equity (TTM) in Millions	12,309	12,309	12,309	12,309	13,488
Seq. Equity Change	0 %	0 %	0 %	-8.74 %	0 %
Seq. Net Income Change	-	-	-	-	-

Back to PHG Management Effectiveness >> PHG's 5 Years Annual ROE >> Compare PHG ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 9
Sector	# 138
Overall	# 2800

Return On Equity Statistics
High	Average	Low
22.96 %	4.49 %	-12.08 %
(Dec 31 2021)		(Dec 31 2022)

PHG Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	12,309	13,488	13,508	14,877	16,212
Y / Y Equity Change	-8.74 %	-0.15 %	-9.2 %	-8.23 %	-1.04 %
Net Income in Millions	1,005	-782	-519	-1,798	3,722
Y / Y Net Income Change	-	-	-	-	178.08 %
Return On Equity	8.16 %	-5.8 %	-3.84 %	-12.08 %	22.96 %

Back to PHG Management Effectiveness >> PHG's 5 Years Annual ROE >> Compare PHG ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 8.16 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PHG's' Return on Equity at Yahoo Finance
PHG's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PHG's Competitors
Subscribers only: Roe for Koninklijke Philips Nv's Suppliers
Subscribers only: Return On Equity for PHG's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Iqvia Holdings Inc	22.05 %
Ge Healthcare Technologies Inc	21.90 %
Msa Safety Inc	21.82 %
Mimedx Group Inc	21.24 %
Universal Health Services Inc	21.19 %
Inspire Medical Systems inc	21.07 %
Astrazeneca Plc	21.00 %
Haemonetics Corporation	20.80 %
Sbc Medical Group Holdings Incorporated	20.79 %
Lantheus Holdings Inc	20.58 %
Electromed Inc	20.54 %
Teva Pharmaceutical Industries Limited	20.07 %
Harmony Biosciences Holdings inc	19.84 %
Pediatrix Medical Group Inc	19.58 %
United Therapeutics Corporation	19.30 %
Krystal Biotech Inc	18.69 %
Argenx Se	17.64 %
Kewaunee Scientific Corporation	17.52 %
Black Diamond Therapeutics Inc	17.46 %
Insulet Corporation	17.36 %
Ufp Technologies Inc	17.36 %
West Pharmaceutical Services Inc	16.68 %
Neurocrine Biosciences Inc	16.67 %
Ensign Group Inc	16.57 %
Ani Pharmaceuticals Inc	16.48 %
Genmab A	16.47 %
Strata Critical Medical Inc	16.46 %
Intuitive Surgical Inc	16.40 %
Cryoport inc	15.75 %
Lemaitre Vascular Inc	15.58 %

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.